SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired Paragon 28, Inc. (NYSE: FNA) common stock between May 5, 2024 and August 8, 2024. Paragon 28 "develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The ...

PHILADELPHIA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA). The lawsuit has been filed on behalf of purchasers of Paragon 28 securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"). CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired PARAGON 28 securities during the Class Period may, no later than NOVEMBER 29, 2024, seek to be appointed as a lead p ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA) securities during the period of May 5, 2023 through August 8, 2024, inclusive ("the Class Period"). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit. [Click here ...

Core Viewpoint - A class action lawsuit has been filed against Paragon 28, Inc. and certain executives for alleged violations of federal securities laws during the class period from May 5, 2023, to August 8, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit includes all individuals and entities that purchased or acquired Paragon 28 common stock, call options, or sold put options during the specified class period [1][2]. - Investors have until November 29, 2024, to seek appointment as lead plaintiff in the class action lawsuit [2]. Group 2: Allegations Against the Company - The lawsuit alleges that the defendants made materially false and misleading statements regarding Paragon 28's business operations and financial reporting, specifically understating costs and overstating inventories [5]. - The company announced on July 30, 2024, that its previously issued financial statements for the fiscal year ended December 31, 2023, and certain quarterly reports should no longer be relied upon due to errors, leading to a stock price drop of $1.24 per share, or 13.7% [6]. - On August 8, 2024, Paragon 28 filed amended financial reports that included restated figures, resulting in a further stock price decline of $1.67 per share, or 20% [7]. Group 3: Company Overview - Paragon 28 develops, distributes, and sells orthopedic surgical implants for foot and ankle procedures [4].

LOS ANGELES, Oct. 10, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Paragon 28, Inc. ("Paragon" or the "Company") (NYSE: FNA). Class Period: May 5, 2023 – August 8, 2024 Lead Plaintiff Deadline: November 29, 2024 If you are a shareholder who suffered a loss, click here to participate. The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose t ...

PHILADELPHIA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE: FNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"). Investors that suffered losses from PARAGON 28 (NYSE: FNA) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn more about the lawsu ...

LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 29, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Paragon 28, Inc. ("Paragon" or the "Company") (NYSE: FNA) common stock between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"). If you suffered a loss on your Paragon investments or would like to inquire about potentially pursuing claim ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 ...

SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired Paragon 28, Inc. (NYSE: FNA) common stock between May 5, 2024 and August 8, 2024. Paragon 28 "develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The ...

NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and August 8, 2024, both dates inclusive (the "Class Period") and those who purchased Paragon 28 call options or sold put options during the Class Period. A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than Novembe ...